Buy Idrinol capsules 250 mg 40 pcs
  • Buy Idrinol capsules 250 mg 40 pcs

Mildronate® [Meldonium]

Mildronate is a trade name of Meldonium. It is used to treat several cardiovascular and cerebrovascular conditions as well as fatigue. Mildronate also used as a performance-enhancing drug, althought there is few evidence that it can significantly improve physical performance.

1087 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$23.45
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Meldonium (primarily known as Mildronate) is a cardiac medication, also widely known as performance-enhancing drug.

Mildronate approved for medical use in Russia and some eastern European countries to treat ischemic heart disease, cerebrovascular disorders, mental and physical exhaustion, and alcohol withdrawal syndrome.

The main mechanism of action of Mildronate is inhibition of carnitine biosynthesis. Inhibition of carnitine biosynthesis, transport, and reabsorption prevents the accumulation of cytotoxic intermediate products of fatty acid oxidation in ischemic tissues. Moreover, cell metabolism shifts to increased glucose consumption, which is beneficial in ischemic conditions, since the oxidation of glucose requires less oxygen.

Besides having cardioprotective effect, Mildronate has neuroprotective action as suggested by several studies [neuroprotective]. In clinical trials on patients suffering from cerebrovascular disorders, the drug shown to improve patients’ overall mood and condition, and relieve chronic fatigue and nausea.

You can read more about Meldonium and its mechanism of action here.

Meldonium is marketed under different brands and generic names, and comes in different dosage forms:

Brand nameManufacturerCountryDosage form
Idrinol Sotex Russia capsules
Idrinol Sotex Russia solution
Idrinol Sotex Russia ampoules
Cardionate Nizhpharm Russia solution
Cardionate Nizhpharm Russia capsules
Mildronate® Grindex Latvia capsules
Mildronate® Grindex Latvia ampoules

No customer reviews for the moment.

Write your review

Write your review

Mildronate® [Meldonium]

Dosage and Administration

For oral use.

Disruption of cerebral circulation: in the acute phase of cerebrovascular disease, an injection form of the drug is used for 10 days, after which it is administered orally at 500 mg / day. The course of treatment is 4-6 weeks.

Chronic disorders of cerebral circulation: 500 mg / day, preferably in the morning. The course of treatment is 4-6 weeks. Repeated courses - 2-3 times a year.

In cardiology in complex therapy: 0.5–1 g per day. The course of treatment is 4-6 weeks.

Cardialgia on the background of dyshormonal dystrophy of the myocardium: 250 mg 2 times a day (morning and evening). The course of treatment is 12 days.

Mental and physical overloads (including athletes): adults, 250 mg 4 times a day. The course of treatment is 10-14 days. If necessary, repeat the treatment after 2–3 weeks.

At 0.5–1 g 2 times a day before training; preferably in the morning. The duration of the course during the preparatory period is 14–21 days, and during the competition period it is 10–14 days.

Abstinence alcohol syndrome: 500 mg 4 times a day. The course of treatment is 7-10 days.

Adverse reactions

Since the cardiovascular system: rarely - tachycardia, decrease or increase in blood pressure.

From the side of the central nervous system: rarely - psychomotor agitation.

On the part of the digestive system: rarely - dyspeptic disorders.

Allergic reactions: rarely - pruritus, rash, hyperemia of the skin, angioedema; very rarely - eosinophilia.

Other: very rarely - general weakness.

Contraindications

hypersensitivity;

increased intracranial pressure (in violation of the venous outflow and intracranial tumors);

pregnancy;

lactation period;

children's age up to 18 years.

With care: diseases of the liver and / or kidneys.

Drug interactions

Can be combined with antianginal agents, anticoagulants, antiplatelet agents, antiarrhythmic agents, diuretics, bronchodilators.

Enhances the action of cardiac glycosides.

Due to the possible development of moderate tachycardia and hypotension, caution should be exercised in combination with nitroglycerin, nifedipine, alpha-blockers, antihypertensives and peripheral vasodilators.

Pregnancy and Lactation

The safety of the drug during pregnancy is not proven. In order to avoid possible adverse effects on the fetus should not be prescribed the drug during pregnancy.

It is not known whether the drug is excreted in breast milk. If necessary, the use of the drug Idrinol during lactation breastfeeding should be discontinued.

Special instructions

Idrinol is not a first-line drug for acute coronary syndrome.

Influence on ability to drive vehicles and mechanisms

Data on the adverse effects of the drug Idrinol on the speed of psychomotor reactions is not available.

Overdosage

Symptoms: decrease in blood pressure, accompanied by headache, tachycardia, dizziness and general weakness.

Treatment: symptomatic.

  • Brand name: Idrinol
  • Active ingredient: Meldonium
  • Dosage form: Capsules
  • Manufacturer: Sotex

Studies and clinical trials of Meldonium (Click to expand)

  1. UPLC-MS/MS method for bioequivalence study of oral drugs of meldonium
  2. Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis
  3. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry
  4. Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity
  5. The experimental research of endothelio- and cardioprotective eff ECTS of meldonium and trimetazidine in comparison in the model of nitric oxide deficiency
  6. Multimodal meldonium's influence on functional brain state
  7. Sixty seconds on . . . meldonium
  8. Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes
  9. Meldonium (Mildronate): A Performance-Enhancing Drug?
  10. Misuse of the metabolic modulator meldonium in sports
  11. Rapid determination of meldonium in urine samples by capillary electrophoresis with capacitively coupled contactless conductivity detection
  12. Meldonium (Mildronate): Primum nоn nocere
  13. Response to comment by Sergei V. Jargin: “Meldonium (Mildronate): primum nоn nocere”
  14. Carnitine and γ-Butyrobetaine Stimulate Elimination of Meldonium due to Competition for OCTN2-mediated Transport
  15. Story behind meldonium–from pharmacology to performance enhancement: a narrative review
  16. The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers
  17. Outbreak in meldonium positive laboratory tests: are we missing something?
  18. Meldonium
  19. Meldonium use by athletes at the Baku 2015 European Games: Table 1
  20. Pharmacokinetics and Pharmacodynamics of Meldonium in Exercised Thoroughbred Horses
  21. AB0828 Effects of meldonium for chronic heart failure after miocarditis in patients with connective tissue disease
  22. Determination of Meldonium in human urine by HPLC with tandem mass spectrometric detection
  23. Urinary excretion studies of meldonium after multidose parenteral application

Customers who bought this product also bought:

Afala

Price $27.00
(0)

8 other products in the same category:

arrow_upward